10.6084/m9.figshare.11834244.v1
Sarah Dewilde
Sarah
Dewilde
Kevin Carroll
Kevin
Carroll
Emilia Nivelle
Emilia
Nivelle
James Sawyer
James
Sawyer
Additional file 4 of Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective
Springer Nature
2020
Cost-effectiveness
Dexrazoxane
Prevention
Anthracycline
Cardiotoxicity
Sarcoma
Haematologic malignancy
2020-02-11 05:31:42
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_4_of_Evaluation_of_the_cost-effectiveness_of_dexrazoxane_for_the_prevention_of_anthracycline-related_cardiotoxicity_in_children_with_sarcoma_and_haematologic_malignancies_a_European_perspective/11834244
Additional file 4. Summary of healthcare cost data sources. Table showing a summary of healthcare cost data sources.